Assenagon Asset Management
TTOO

Assenagon Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Assenagon Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25
Closed -$381K – 1150
2018
Q4 		$381K Buy
+25
New +$587K ﹤0.01% 877

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management's TTOO Position: Q1 2019 in Review

Assenagon Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2019, closing a stake of 25 shares — an estimated $381K sold.

Assenagon Asset Management first reported a position in TTOO in Q4 2018 and held it in 1 quarter. The position peaked at $381K in Q4 2018. 71 funds tracked by Wall St. Rank hold TTOO as of Q1 2019.

  • Assenagon Asset Management reported no remaining T2 Biosystems, Inc position as of Q1 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 25 T2 Biosystems, Inc shares in Q1 2019, an estimated $381K.
  • Assenagon Asset Management first reported a position in T2 Biosystems, Inc in Q4 2018 and held it in 1 quarter.
  • Assenagon Asset Management's T2 Biosystems, Inc position peaked at $381K in Q4 2018.
  • 71 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2019.

Based on Assenagon Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.